15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Aspen Aerogels Inc, 3 rate it Buy or better, 0 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets range widely, $3.00 to $6.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $4.50 sits 2% above the current $4.40. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near -32% this year and 48% next, consensus EPS building from about $-0.13 next quarter toward $-0.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold00%
Sell125%
Strong Sell00%
Based on 4 analysts giving stock ratings to Aspen Aerogels Inc.
As of Jul, 3 of 4 firms rate ASPN a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
ASPN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.13
Range $-0.16 – $-0.08 · 4 analysts · +113% YoY
Next period, 4 analysts expect Aspen Aerogels Inc to earn $-0.13 a share (range $-0.16 – $-0.08), versus $-0.06 a year earlier. Full-year consensus is $-0.72, growing to $-0.10 the year after.
REVENUE · NEXT QUARTER
$56.9M
Range $43.9M – $64.7M · 4 analysts · -47% YoY
Revenue is expected to reach $56.9M (range $43.9M – $64.7M), -47.0% year-over-year. Full-year consensus is $196.2M, rising to $283.9M next year.
Top analysts covering Aspen Aerogels Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ASPN.
#1
Eric Stine
Craig-Hallum · Rank #124
Buy
$18.00+309.1% to target
Overall win rate
44%
+ Follow
#2
Colin Rusch
Oppenheimer · Rank #160
Hold
No targeton ASPN
Overall win rate
39%
+ Follow
#3
David Anderson
Barclays · Rank #175
Sell
$4.00-9.1% to target
Overall win rate
44%
+ Follow
#4
George Gianarikas
Canaccord Genuity · Rank #222
Buy
$5.00+13.6% to target
Overall win rate
37%
+ Follow
#5
Chip Moore
Roth MKM · Rank #263
Buy
$3.00-31.8% to target
Overall win rate
28%
+ Follow
ASPN stock forecast FAQ
What is ASPN's average 12-month price target?+
The 4 analysts with a live target average $4.50 for Aspen Aerogels Inc over the next 12 months, ranging from a $6.00 high to a $3.00 low.
Is ASPN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for ASPN?+
The Street-high target is $6.00 (TD Cowen), and the Street-low is $3.00 (Roth Capital). The average of all 4 active targets is $4.50.
How many Wall Street analysts cover ASPN?+
4 analysts have an active rating on Aspen Aerogels Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering ASPN?+
Among analysts who currently cover ASPN, Eric Stine of Craig-Hallum has the strongest overall Quantellect track record (Rank #124). Their current call is Buy with a $18.00 target.
What is Aspen Aerogels Inc's projected EPS for next quarter?+
The consensus estimate is $-0.13 per share (range $-0.16 – $-0.08) across 4 analysts. Full-year EPS is projected at $-0.72, rising to $-0.10 the following year.
How much revenue is Aspen Aerogels Inc expected to report next quarter?+
Consensus revenue is $56.9M (range $43.9M – $64.7M). Full-year revenue is projected at $196.2M, growing to $283.9M next year.
Have analysts been upgrading or downgrading ASPN lately?+
As of Jul, 3 of 4 firms rate ASPN a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ASPN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
